Section

Health & Medicine

Breakthroughs in medical research, pharmaceuticals, longevity science, and the future of healthcare.

Pfizer's giant hand shaking Metsera's smaller hand, symbolizing a $4.9 billion acquisition deal amidst a backdrop of glowing drug molecules and market growth charts.

Pfizer acquires Metsera in $4.9B deal amid biotech boom

Pfizer will pay $4.9 billion to acquire Metsera, a company whose shares debuted at just $18, after its lead obesity candidate showed 11.3% weight loss in early trials, according to Biospace . This mul

Maria Flores· Jun 29· 3 min read

Rehabilitation After Surgery or Joint Replacement With Dynamic in-Home Care

Sponsored by Dynamic In-Home Care · Aug 10

How InkBeetle Uses Natural Ingredients to Create a Breathable Barrier for Faster Healing (Pro Tips)

Beyond the Chart: Why Frustrated Patients Are Switching to PCP Health in Port Charlotte

WHO Declares Global Emergency Over Ebola Outbreak

Dr. Chloe O'Connell · Jun 14

Medical and public health experts collaborating on redefining obesity as a complex condition, not a single disease.

Obesity disease label challenges clinical definitions and public health

In a landmark January 2025 finding, an international commission concluded that classifying obesity as a single, uniform disease is incompatible with its varied manifestations, according to Nature .

Maria Flores· Jun 1· 3 min

Microscopic view of senescent cells being identified by glowing blue aptamer molecules in a laboratory setting, representing a breakthrough in longevity research.

Scientists use aptamers to identify aging cells in longevity research

A low-dose, 1mg/day regimen of rapamycin improved diastolic heart function in older men in just eight weeks, according to gethealthspan .

Maria Flores· May 19· 3 min

Analysis & Trends

Science-Backed Habits for a Longer, Healthier Life

Maria Flores · Jun 29